The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
Abstract
New meningococcal vaccines are undergoing clinical trials, and changes in the epidemiologic features of meningococcal disease will affect their use. Active laboratory-based, population-based US surveillance for meningococcal disease during 1992-1996 was used to project that 2400 cases of meningococcal disease occurred annually. Incidence was highest in infants; however, 32% of cases occurred in persons >/=30 years of age. Serogroup C caused 35% of cases; serogroup B, 32%; and serogroup Y, 26%. Increasing age (relative risk [RR], 1.01 per year), having an isolate obtained from blood (RR, 4.5), and serogroup C (RR, 1.6) were associated with increased case fatality. Among serogroup B isolates, the most commonly expressed serosubtype was P1.15; 68% of isolates expressed 1 of the 6 most common serosubtypes. Compared with cases occurring in previous years, recent cases are more likely to be caused by serogroup Y and to occur among older age groups. Ongoing surveillance is necessary to determine the stability of serogroup and serosubtype distribution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics
Selander, R. K., Caugant, D. A., Ochman, H., Musser, J. M., Gilmour, M. N., & Whittam, T. S. (1986) · Applied and Environmental Microbiology · doi:10.1128/aem.51.5.873-884.1986 · Cited by 1,385
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Self-citationEffect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, Ø., Fredriksen, J. H., Lindbak, A.-K., Nøkleby, H., Rosenqvist, E., Solberg, L. K., Closs, O., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91961-s · Cited by 694
Sierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Treatment of Bacterial Meningitis
Quagliarello, V. J., & Scheld, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361007 · Cited by 491
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
Cassio de Moraes, J., Camargo, M. C. C., Rossetto Hidalgo, N. T., Aparecida Barbosa, H., Gattas, V. L., Vasconcelos, H. D. G., Tavares Sacchi, C., Land Gral, I. M., Perkins, B. A., Wenger, J. D., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)93086-3 · Cited by 366
Self-citationAsymptomatic carriage of Neisseria meningitidis in a randomly sampled population
Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J., & Frøholm, L. O. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.323-330.1994 · Cited by 312
Gender and inequalities in health in later life
Arber, S., & Ginn, J. (1993) · Social Science & Medicine · doi:10.1016/0277-9536(93)90303-l · Cited by 306
Serogroup C meningococcal outbreaks in the United States. An emerging threat
Jackson, L. A. (1995) · JAMA · doi:10.1001/jama.273.5.383 · Cited by 256
Cited by
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,169
Self-citationEpidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Self-citationThe Epidemiology of Severe Sepsis in Children in the United States
Watson, R. S., Carcillo, J. A., Linde-Zwirble, W. T., Clermont, G., Lidicker, J., & Angus, D. C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-682oc · Cited by 874
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
Giefing‐Kröll, C., Berger, P., Lepperdinger, G., & Grubeck‐Loebenstein, B. (2015) · Aging Cell · doi:10.1111/acel.12326 · Cited by 761
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Self-citationA universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Clinical recognition of meningococcal disease in children and adolescents
Thompson, M. J., Ninis, N., Perera, R., Mayon-White, R., Phillips, C., Bailey, L., Harnden, A., Mant, D., & Levin, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67932-4 · Cited by 565
Neisseria meningitidis: Biology, Microbiology, and Epidemiology
Rouphael, N. G., & Stephens, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-346-2_1 · Cited by 425
Self-citationInfections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Aricò, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021911 · Cited by 395
NadA, a Novel Vaccine Candidate of Neisseria meningitidis
Comanducci, M., Bambini, S., Brunelli, B., Adu-Bobie, J., Aricò, B., Capecchi, B., Giuliani, M. M., Masignani, V., Santini, L., Savino, S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020407 · Cited by 351
Cohn, A. C., MacNeil, J. R., Harrison, L. H., Hatcher, C., Theodore, J., Schmidt, M., Pondo, T., Arnold, K. E., Baumbach, J., Bennett, N., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649209 · Cited by 345
Self-citationHow Contagious Are Common Respiratory Tract Infections?
Musher, D. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021771 · Cited by 301
Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168
Brooks, R., Woods, C. W., Benjamin, Jr., & Rosenstein, N. E. (2006) · Clinical Infectious Diseases · doi:10.1086/504804 · Cited by 124
Self-citationClassification and Pathogenesis of Meningococcal Infections
Brandtzaeg, P., & van Deuren, M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-346-2_2 · Cited by 99
A prospective study of etiology of childhood acute bacterial meningitis, Turkey
Ceyhan, M., Yildirim, I., Balmer, P., Borrow, R., Dikici, B., Turgut, M., Kurt, N., Aydogan, A., Ecevit, C., Anlar, Y., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.070938 · Cited by 97
Effectiveness of meningococcal serogroup C vaccine programmes
Borrow, R., Abad, R., Trotter, C., van der Klis, F. R. M., & Vazquez, J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.083 · Cited by 88
Ceyhan, M., Gürler, N., Ozsurekci, Y., Keser, M., Aycan, A. E., Gurbuz, V., Salman, N., Camcioglu, Y., Dinleyici, E. C., Ozkan, S., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29678 · Cited by 60
SÄLL, O., STENMARK, B., GLIMÅKER, M., JACOBSSON, S., MÖLLING, P., OLCÉN, P., & FREDLUND, H. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817000929 · Cited by 29
Metadata
- Authors
- Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Lefkowitz, L., Cartter, M. L., Danila, R., Cieslak, P., Shutt, K. A., Popovic, T., Schuchat, A., Harrison, L. H., Reingold, A. L., & the Active Bacterial Core Surveillance Team
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12
- Volume
- 180
- Issue
- 6
- Pages
- 1894-1901
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2146766894
- Cited by
- 449
- References
- 27
- FWCI
- 17.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.